Richard E - Search Results

1

Association of Angiotensin II-Stimulating Antihypertensive Use and Dementia Risk: Post Hoc Analysis of the PreDIVA Trial.

van Dalen JW, Marcum ZA, Gray SL, Barthold D, Moll van Charante EP, van Gool WA, Crane PK, Larson EB, Richard E. van Dalen JW, et al. Among authors: richard e. Neurology. 2021 Jan 5;96(1):e67-e80. doi: 10.1212/WNL.0000000000010996. Epub 2020 Nov 5. Neurology. 2021. PMID: 33154085 Free PMC article. Clinical Trial.

2

Cholinesterase inhibitors in dementia: yes, no, or maybe?

Lemstra AW, Richard E, van Gool WA. Lemstra AW, et al. Among authors: richard e. Age Ageing. 2007 Nov;36(6):625-7. doi: 10.1093/ageing/afm117. Epub 2007 Sep 19. Age Ageing. 2007. PMID: 17881419 No abstract available.

3

Vascular care in patients with Alzheimer's disease with cerebrovascular lesions-a randomized clinical trial.

Richard E, Kuiper R, Dijkgraaf MG, Van Gool WA; Evaluation of Vascular care in Alzheimer's disease. Richard E, et al. J Am Geriatr Soc. 2009 May;57(5):797-805. doi: 10.1111/j.1532-5415.2009.02217.x. J Am Geriatr Soc. 2009. PMID: 19484836 Clinical Trial.

4

Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress.

Richard E, Van den Heuvel E, Moll van Charante EP, Achthoven L, Vermeulen M, Bindels PJ, Van Gool WA. Richard E, et al. Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):198-204. doi: 10.1097/WAD.0b013e31819783a4. Alzheimer Dis Assoc Disord. 2009. PMID: 19812459 Clinical Trial.

5

Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the evaluation of vascular care in Alzheimer's disease (EVA) study.

Richard E, Gouw AA, Scheltens P, van Gool WA. Richard E, et al. Stroke. 2010 Mar;41(3):554-6. doi: 10.1161/STROKEAHA.109.571281. Epub 2010 Jan 7. Stroke. 2010. PMID: 20056923 Clinical Trial.

6

Morphometric changes in the cortical microvascular network in Alzheimer's disease.

Richard E, van Gool WA, Hoozemans JJ, van Haastert ES, Eikelenboom P, Rozemuller AJ, van de Berg WD. Richard E, et al. J Alzheimers Dis. 2010;22(3):811-8. doi: 10.3233/JAD-2010-100849. J Alzheimers Dis. 2010. PMID: 20858968

7

Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review.

Ligthart SA, Moll van Charante EP, Van Gool WA, Richard E. Ligthart SA, et al. Among authors: richard e. Vasc Health Risk Manag. 2010 Sep 7;6:775-85. doi: 10.2147/vhrm.s7343. Vasc Health Risk Manag. 2010. PMID: 20859546 Free PMC article. Review.

8

Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern?

Thoonsen H, Richard E, Bentham P, Gray R, van Geloven N, De Haan RJ, Van Gool WA, Nederkoorn PJ. Thoonsen H, et al. Among authors: richard e. Stroke. 2010 Nov;41(11):2690-2. doi: 10.1161/STROKEAHA.109.576975. Epub 2010 Oct 7. Stroke. 2010. PMID: 20930165 Review.

9

Characteristics of dyshoric capillary cerebral amyloid angiopathy.

Richard E, Carrano A, Hoozemans JJ, van Horssen J, van Haastert ES, Eurelings LS, de Vries HE, Thal DR, Eikelenboom P, van Gool WA, Rozemuller AJ. Richard E, et al. J Neuropathol Exp Neurol. 2010 Nov;69(11):1158-67. doi: 10.1097/NEN.0b013e3181fab558. J Neuropathol Exp Neurol. 2010. PMID: 20940625

10

Alzheimer’s disease/syndrome?. There are two types of disease.

Richard E, Van Gool WA. Richard E, et al. BMJ. 2010 Nov 16;341:c6327. doi: 10.1136/bmj.c6327. BMJ. 2010. PMID: 21081609 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

637 results

Search Page